Korean drugmakers seeking to develop new business models

Local pharmaceutical companies are scrambling to find new business models against a deteriorating business environment in the aftermath of the government’s forced price cut for drugs and other medical products covered by National Health Insurance.

It looks as if a series of recent government policies and outside pressures are at last forcing the pharmaceuticals to change their problematic bu...